Literature DB >> 18936993

Can we afford to ignore missing data in cost-effectiveness analyses?

Andrea Marshall, Lucinda J Billingham, Stirling Bryan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 18936993     DOI： 10.1007/s10198-008-0129-y

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  3 in total

1.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Authors:  Arduino Verdecchia; Silvia Francisci; Hermann Brenner; Gemma Gatta; Andrea Micheli; Lucia Mangone; Ian Kunkler
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

2.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

Authors:  M Sant; T Aareleid; F Berrino; M Bielska Lasota; P M Carli; J Faivre; P Grosclaude; G Hédelin; T Matsuda; H Møller; T Möller; A Verdecchia; R Capocaccia; G Gatta; A Micheli; M Santaquilani; P Roazzi; D Lisi
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

3.  Estimates of the cancer incidence and mortality in Europe in 2006.

Authors:  J Ferlay; P Autier; M Boniol; M Heanue; M Colombet; P Boyle
Journal:  Ann Oncol       Date:  2007-02-07       Impact factor: 32.976
  3 in total
  7 in total

1.  Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial.

Authors:  Ilias Goranitis; Leana Bellanca; Amanda J Daley; Adele Thomas; Helen Stokes-Lampard; Andrea K Roalfe; Sue Jowett
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

2.  Missing data in trial-based cost-effectiveness analysis: An incomplete journey.

Authors:  Baptiste Leurent; Manuel Gomes; James R Carpenter
Journal:  Health Econ       Date:  2018-03-24       Impact factor: 3.046

Review 3.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.

Authors:  Andrea Gabrio; Alexina J Mason; Gianluca Baio
Journal:  Pharmacoecon Open       Date:  2017-06

4.  Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial.

Authors:  Baptiste Leurent; Manuel Gomes; Rita Faria; Stephen Morris; Richard Grieve; James R Carpenter
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

5.  Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial.

Authors:  Modou Diop; David Epstein
Journal:  Cost Eff Resour Alloc       Date:  2022-04-07

6.  Economic evaluation of internet-based interventions for harmful alcohol use alongside a pragmatic randomized controlled trial.

Authors:  Matthijs Blankers; Udo Nabitz; Filip Smit; Maarten W J Koeter; Gerard M Schippers
Journal:  J Med Internet Res       Date:  2012-10-29       Impact factor: 5.428

7.  Routine real-time cost-effectiveness monitoring of a web-based depression intervention: a risk-sharing proposal.

Authors:  Klemen Naveršnik; Aleš Mrhar
Journal:  J Med Internet Res       Date:  2014-02-27       Impact factor: 5.428
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.